Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.

• 主要な著者: Romain Guery (著者), Benoit Henry (著者), Guillaume Martin-Blondel (著者), Claire Rouzaud (著者), Florence Cordoliani (著者), Gundel Harms (著者), Jean-Pierre Gangneux (著者), Françoise Foulet (著者), Emmanuelle Bourrat (著者), Michel Baccard (著者), Gloria Morizot (著者), Paul-Henri Consigny (著者), Antoine Berry (著者), Johannes Blum (著者), Olivier Lortholary (著者), Pierre Buffet (著者), French Cutaneous Leishmaniasis Study group & the LeishMan network (著者)
• フォーマット: 図書
• 出版事項: Public Library of Science (PLoS), 2017-11-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Complex cutaneous and muco-cutaneous leishmaniasis (CL and MCL) often requires systemic therapy. Liposomal amphotericin B (L-AmB) has a strong potential for a solid clinical benefit in this indication.We conducted a retrospective analysis of data from a French centralized referral treatment program...